Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

JPMorgan Chase & Co. (JPM), Bank of America Corp (BAC): The Decision to Spin Off a Private Equity Unit Could Impact Investors in a Big Way

Page 1 of 2
JPMorgan Chase & Co. (NYSE:JPM) recently announced its intention to divest its private equity arm in response to long-awaited regulatory changes and volatile swings in profitability. Known as One Equity Partners, the private equity division has been a longstanding point of contention for JP Morgan’s management team, as well as members of the broader investment community. It appears that opponents of the division’s continued attachment to JPMorgan Chase & Co. (NYSE:JPM) have finally won the day.

JPMorgan Chase & Co (NYSE:JPM)

Although retail investors will probably be unable to throw in their lots with the new company, this deal could have important ramifications for JPMorgan Chase & Co. (NYSE:JPM)’s organizational structure and future growth plans. It could also presage similar moves by other big banks. In fact, a rush to comply with the provisions of the so-called Volcker rule and some additional pieces of regulation has led to private-equity divestitures across the industry. Investors with interest in large-cap banks would do well to remain informed about this transaction.

JP Morgan and the Competition at a Glance

As one of the largest U.S.-based banks in existence, JPMorgan Chase & Co. (NYSE:JPM) competes with other highly diversified “household name” banks like Bank of America Corp (NYSE:BAC) and Citigroup Inc (NYSE:C). With enormous revenue figures and globe-spanning operational structures, these firms are alike in many important ways. Until recently, market-watchers deemed JPMorgan Chase & Co. (NYSE:JPM) to be the strongest and most stable of the bunch.

For starters, their market capitalization figures are all comfortably in the 11-figure range. With a valuation of nearly $205 billion, JP Morgan leads the pack. With a market capitalization of just under $153 billion, Citigroup Inc (NYSE:C) is not too far behind. Bank of America Corp (NYSE:BAC)’s shares are worth around $142 billion in the aggregate.

Revenues and profits tell a similar story. In 2012, JP Morgan earned a solid $21.4 billion on revenues of about $92 billion. This compares quite favorably with Citigroup Inc (NYSE:C)’s take of $8.4 billion on revenues of $61 billion. Bank of America Corp (NYSE:BAC) had a much narrower margin: it took in about $78 billion in revenue but posted a profit of just over $3.5 billion. Fortunately, all three of these firms appear to be in good financial shape. Bank of America Corp (NYSE:BAC)’s debts add up to about $618 billion and offset a cash hoard of just over $500 billion. JPMorgan Chase & Co. (NYSE:JPM) and Citigroup Inc (NYSE:C) enjoy similar ratios.

How the Deal Will Happen

Few hard details about this spin-off have been released. However, JP Morgan’s CEO has indicated that One Equity will no longer raise capital from JP Morgan’s clients or accept infusions of cash from its former parent company. Although the firm will receive limited support during its transition to full independence, it will have its own internal management team. Meanwhile, JP Morgan will completely exit the private equity business to focus on its core banking and trading operations.

Although JP Morgan has not provided explicit guidance on the structure of the newly independent One Equity Partners, it appears that the firm will not trade as a public company. Rather, it appears likely that it will solicit large-scale investments from institutional clients like other private equity firms, hedge funds and pension funds. However, it would be foolish to assume that a public offering is off the table for the foreseeable future. As such, investors would be wise to keep an eye on One Equity.

Good or Bad for JPM?

This deal will represent a major change for JP Morgan. On the positive side, the bank will divest a volatile asset that has seen its share of troubles over the past decade. Of course, it will also sacrifice potential revenue from well-structured deals. Operationally, the company will be a bit more streamlined and may be able to put the cash that it would set aside One Equity to use in other ways. Overall, JP Morgan will emerge from this spin-off as a more conservative company that fully complies with the confusing mix of new banking regulations to which it and its peers are required to adhere.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!